MitoQ
PrivateCompany Overview
MitoQ is a biotechnology company that develops and sells a patented, mitochondria-targeted antioxidant supplement designed to combat cell stress and support organ health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, E-commerce
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoQ Comparables
Compare MitoQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amazentis | 88% | |
| Elysium Health | 87% | |
| NOVOS | 82% | |
MitoQ Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors grew 34% MoM, reaching 80.9K.
MitoQ Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoQ's valuation, stock price, and market status.